Compounds > vancomycin
Page last updated: 2024-08-21

vancomycin and Phlebitis

vancomycin has been researched along with Phlebitis in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19903 (42.86)18.7374
1990's2 (28.57)18.2507
2000's2 (28.57)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Palau, E; Picazo, JJ; Portolés, A; Puerro, M; Vargas, E1
Farber, BF; Moellering, RC1
Fiorilli, MG; Fisher, CH; Maradiaga, CM1
Bodey, GP; Elting, LS; Fangtang, J; Kurtin, D; Manzullo, E; Martin, CG; Raad, II; Rolston, KV; Rubenstein, EB; Whimbey, EE1
Gouin, F; Pham Dang, C; Potel, G; Richard, C; Touchais, S1
Dolezal, JM; Downs, NJ; Hodges, GR; Neihart, RE1
Ast, D; Garrelts, JC; LaRocca, J; Peterie, JD; Smith, DF1

Trials

1 trial(s) available for vancomycin and Phlebitis

ArticleYear
[The comparative costs of vancomycin treatment versus teicoplanin in osteoarticular infection caused by methicillin-resistant staphylococci].
    Pathologie-biologie, 2001, Volume: 49, Issue:7

    Topics: Acute Disease; Aged; Anti-Bacterial Agents; Arthritis, Infectious; Catheterization, Central Venous; Chronic Disease; Drug Costs; Drug Hypersensitivity; Female; France; Health Care Costs; Humans; Infusions, Intravenous; Kidney Diseases; Male; Methicillin Resistance; Middle Aged; Osteitis; Phlebitis; Pneumothorax; Postoperative Complications; Prospective Studies; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Syndrome; Teicoplanin; Vancomycin

2001

Other Studies

6 other study(ies) available for vancomycin and Phlebitis

ArticleYear
Health economics assessment study of teicoplanin versus vancomycin in Gram-positive infections.
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2006, Volume: 19, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cost-Benefit Analysis; Drug Administration Routes; Drug Costs; Drug Monitoring; Drug Utilization; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Hospital Costs; Hospitals, Urban; Humans; Length of Stay; Male; Middle Aged; Phlebitis; Prospective Studies; Renal Dialysis; Spain; Teicoplanin; Vancomycin

2006
Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981.
    Antimicrobial agents and chemotherapy, 1983, Volume: 23, Issue:1

    Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Drug Eruptions; Female; Fever; Humans; Infant; Kidney; Male; Middle Aged; Neutropenia; Phlebitis; Retrospective Studies; Time Factors; Vancomycin

1983
Diphenhydramine/vancomycin admixture for infusion phlebitis.
    The Annals of pharmacotherapy, 1996, Volume: 30, Issue:12

    Topics: Adult; Anti-Bacterial Agents; Diphenhydramine; Drug Combinations; Female; Histamine H1 Antagonists; Humans; Infusions, Intravenous; Phlebitis; Vancomycin

1996
Mississippi mud in the 1990s: risks and outcomes of vancomycin-associated toxicity in general oncology practice.
    Cancer, 1998, Dec-15, Volume: 83, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Microbial; Female; Hearing Disorders; Humans; Immunocompromised Host; Kidney; Male; Middle Aged; Neoplasms; Phlebitis; Prospective Studies; Regression Analysis; Vancomycin

1998
Mild nephrotoxicity associated with vancomycin use.
    Archives of internal medicine, 1989, Volume: 149, Issue:8

    Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Creatinine; Drug Interactions; Drug Therapy, Combination; Humans; Infusions, Intravenous; Kidney; Male; Middle Aged; Neutropenia; Phlebitis; Risk Factors; Vancomycin

1989
Phlebitis associated with vancomycin therapy.
    Clinical pharmacy, 1988, Volume: 7, Issue:10

    Topics: Humans; Injections, Intravenous; Phlebitis; Vancomycin

1988